博瑞医药拟以5000万元增资极客基因

Core Viewpoint - The company, Borui Pharmaceutical, announced an investment of 50 million yuan in Suzhou Geek Gene Technology, increasing its stake from 4.0816% to 12.8015% [2] Group 1: Investment Details - The investment includes a subscription to the new registered capital of 437,100 yuan, with the remaining amount allocated to the capital reserve of Geek Gene [2] - This investment aligns with the company's innovation-driven development strategy [2] Group 2: Strategic Implications - The collaboration is expected to leverage both companies' strengths in innovative drug development and cell therapy technology [2] - Geek Gene possesses unique technological advantages in areas such as cell fate reprogramming and low-cost high-throughput omics technology, which may create potential synergies with the company's product development [2]